Skip to content

Clinical trials

Bone Diseases trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Diseases Country / region: Spain Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20125
20151
20162
20171
20191
20201
20214
20221
20231
20244
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Enrolling by invitation4
Recruiting4
Active, not recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
QED Therapeutics, a BridgeBio company8
BioMarin Pharmaceutical4
Amgen3
Alexion Pharmaceuticals, Inc.2
AstraZeneca1
Banc de Sang i Teixits1
Celgene1
Hospital San Juan de Dios del Aljarafe de Sevilla1
Innoskel1
Kyowa Kirin Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Diseases26
Musculoskeletal Diseases18
Dwarfism13
Osteochondrodysplasias12
Genetic Diseases, Inborn11
Mucopolysaccharidosis IV10
Achondroplasia8
Bone Diseases, Developmental4
Bone Diseases, Metabolic3
Bone Neoplasms2

Trials

Showing 76 to 26 of 26. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.